Literature DB >> 1674162

Cardiovascular reactivity to psychosocial stressors. A review of the effects of beta-blockade.

P J Mills1, J E Dimsdale.   

Abstract

Fifty-nine studies examining the effects of beta-blockers on cardiovascular reactivity to psychosocial stressors are reviewed. Across all classifications of beta-blockers, heart rate reactivity was reduced (p less than 0.0001), while there were no significant changes in either systolic or diastolic blood pressure reactivity. Nonselective beta-blockers were more often associated with a reduction in heart rate reactivity than selective blockers (p less than 0.05). There was no evidence that drug lipophilicity or intrinsic sympathomimetic activity differentially affected blood pressure or heart rate reactivity; nor was there evidence that the reactivity of hypertensive subjects was differentially affected by blockade compared to the reactivity of normotensive subjects. While beta-blockers are effective in reducing resting blood pressure, they are not effective agents in reducing blood pressure reactivity to mild psychosocial stressors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674162     DOI: 10.1016/S0033-3182(91)72094-X

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  14 in total

1.  Dimensions of psychobiologic reactivity: Cardiovascular responses to laboratory stressors in preschool children.

Authors:  W T Boyce; A Alkon; J M Tschann; M A Chesney; B S Alpert
Journal:  Ann Behav Med       Date:  1995-12

Review 2.  Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.

Authors:  Samuel J Mann
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 3.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

4.  Cardiovascular reactions to psychological stress and abuse history: the role of occurrence, frequency, and type of abuse.

Authors:  Annie T Ginty; Nicole A Masters; Eliza B Nelson; Karen T Kaye; Sarah M Conklin
Journal:  Anxiety Stress Coping       Date:  2016-08-02

Review 5.  Drug therapy for resistant hypertension: simplifying the approach.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-08       Impact factor: 3.738

Review 6.  The clinical spectrum of labile hypertension: a management dilemma.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

7.  Psychological characteristics and responses to antihypertensive drug therapy.

Authors:  Samuel J Mann; Linda M Gerber
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738

8.  Combined alpha/beta-blockade: an underused approach to the treatment of resistant hypertension.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-09       Impact factor: 3.738

9.  Psychosomatic research in hypertension: the lack of impact of decades of research and new directions to consider.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-07-26       Impact factor: 3.738

10.  Hostility and physiological responses to laboratory stress in acute coronary syndrome patients.

Authors:  Lena Brydon; Philip C Strike; Mimi R Bhattacharyya; Daisy L Whitehead; Jean McEwan; Ian Zachary; Andrew Steptoe
Journal:  J Psychosom Res       Date:  2009-09-23       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.